{"id":188,"date":"2020-04-01T00:19:13","date_gmt":"2020-04-01T00:19:13","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=188"},"modified":"2023-08-29T18:02:08","modified_gmt":"2023-08-29T18:02:08","slug":"oncosil-medical-obtains-ce-mark-breakthrough-device-designation-pancreatic-tumour-isotope","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=188","title":{"rendered":"OncoSil Medical\u7684\u80f0\u817a\u80bf\u7624\u540c\u4f4d\u7d20\u83b7\u5f97CE\u6807\u5fd7\u548c\u7a81\u7834\u88c5\u7f6e\u8bbe\u8ba1"},"content":{"rendered":"

\u533b\u7597\u8bbe\u5907\u516c\u53f8OncoSil Medical (ASX: OSL)\u5ba3\u5e03\uff0c\u5176\u4e13\u6709\u7684OncoSil\u8bbe\u5907\u7ec8\u4e8e\u83b7\u5f97\u4e86\u82f1\u56fd\u6807\u51c6\u534f\u4f1a(BSI)\u7684CE\u8ba4\u8bc1\uff0c\u8fd9\u662f\u4e00\u79cd\u7ed3\u5408\u5316\u7597\u6cbb\u7597\u5c40\u90e8\u665a\u671f\u80f0\u817a\u764c(LAPC)\u7684\u624b\u6bb5\u3002<\/p>\n

\u8be5\u516c\u53f8\u8868\u793a\uff0cOncoSil\u662f\u4e00\u6d41\u7684\u533b\u7597\u8bbe\u5907\uff0c\u5b83\u7531\u542b\u6709\u78f7-32\u7684\u5fae\u7c92\u7ec4\u6210\uff0c\u78f7-32\u662f\u4e00\u79cd\u7eaf\u7cb9\u7684-\u53d1\u5c04\u5668\u653e\u5c04\u6027\u540c\u4f4d\u7d20\uff0c\u901a\u8fc7\u5185\u955c\u8d85\u58f0\u5f15\u5bfc\u76f4\u63a5\u690d\u5165\u60a3\u8005\u7684\u80f0\u817a\u80bf\u7624\u3002<\/p>\n

\u636e\u8be5\u533b\u7597\u8bbe\u5907\u516c\u53f8\u79f0\uff0c\u8fd9\u4e00\u521d\u6b65\u6279\u51c6\u662f\u4e00\u4e2a\u91cd\u8981\u7684\u91cc\u7a0b\u7891\uff0c\u4e3a\u8be5\u8bbe\u5907\u5728\u6b27\u76df\u548c\u82f1\u56fd\u5e02\u573a\u9500\u552e\u6253\u5f00\u4e86\u5927\u95e8\u3002<\/p>\n

\u8003\u8651\u5230\u6b63\u5728\u8fdb\u884c\u7684\u82f1\u56fd\u9000\u6b27\u8c08\u5224\uff0c\u4ee5\u53ca\u672a\u6765\u51e0\u5e74\u8fd9\u4e24\u4e2a\u5730\u533a\u5728\u5404\u81ea\u8d38\u6613\u653f\u7b56\u4e0a\u53ef\u80fd\u51fa\u73b0\u5206\u6b67\uff0c\u83b7\u5f97\u8fd9\u4e24\u4e2a\u5730\u533a\u7684\u62a4\u7167\u662f\u4e00\u9879\u91cd\u5927\u6210\u5c31\u3002<\/p>\n

OncoSil\u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u603b\u7ecf\u7406\u4e39\u5c3c\u5c14\u2022\u80af\u5c3c(Daniel Kenny)\u8868\u793a:\u201c\u5c06OncoSil\u8bbe\u5907\u6307\u5b9a\u4e3a\u7a81\u7834\u6027\u8bbe\u5907\u662f\u5bf9\u6211\u4eec\u5e73\u53f0\u6280\u672f\u7684\u9a8c\u8bc1\uff0c\u8be5\u6280\u672f\u53ef\u7528\u4e8e\u6cbb\u7597\u591a\u79cd\u5b9e\u4f53\u80bf\u7624\u7c7b\u578b\uff0c\u5982\u809d\u810f\u3001\u80c6\u7ba1\uff0c\u5f53\u7136\u8fd8\u6709\u80f0\u817a\u764c\u3002\u201d<\/p>\n

\u4ed6\u7eed\u8bf4:\u201c\u5728\u53d6\u5f97\u884c\u653f\u957f\u5b98\u8bc4\u5206\u6279\u51c6\u540e\uff0c\u6211\u4eec\u73b0\u5728\u7684\u5de5\u4f5c\u91cd\u70b9\u662f\u5728\u8ba4\u53ef\u884c\u653f\u957f\u5b98\u8bc4\u5206\u8ba4\u8bc1\u7684\u53f8\u6cd5\u7ba1\u8f96\u533a\uff0c\u5904\u7406\u591a\u9879\u6ce8\u518c\u7533\u8bf7\u3002\u201d<\/p>\n

\u80af\u5c3c\u8fd8\u8bc1\u5b9e\uff0c\u5f53\u524d\u7684COVID-19\u5927\u6d41\u884c\u5e76\u672a\u5f71\u54cdOncoSil\u7684\u76d1\u7ba1\u9014\u5f84\uff0c\u4f46\u4ed6\u786e\u5b9e\u8bc1\u5b9e\uff0c\u5927\u6d41\u884c\u5c06\u5f71\u54cd\u8be5\u516c\u53f8\u7684\u4e0a\u5e02\u51c6\u5907\uff0c\u5305\u62ec\u63a8\u8fdfOncoSil\u5728\u6b27\u6d32\u7684\u4e0a\u5e02\u3002<\/p>\n

\u8be5\u516c\u53f8\u9884\u8ba1\uff0c\u5728\u672a\u6765\u51e0\u4e2a\u6708\uff0c\u7531\u4e8e\u65b0\u5de5\u5730\u542f\u52a8\u548c\u57f9\u8bad\u7684\u533b\u9662\u6570\u91cf\u6709\u9650\uff0c\u4ee5\u53ca\u8fd0\u8f93\u548c\u7269\u6d41\u7684\u4e2d\u65ad\uff0c\u5c06\u5bfc\u81f4\u751f\u4ea7\u4e2d\u65ad\u3002<\/p>\n

\u968f\u7740\u591a\u4e2a\u5730\u533a\u7684\u8fd0\u8425\u5f97\u5230\u4fdd\u969c\uff0c\u764c\u529e\u5ba3\u5e03\u5c06\u201c\u7acb\u5373\u5f00\u59cb\u201d\u5728\u8ba4\u53efCE\u8ba4\u8bc1\u7684\u4e1c\u76df\u548c\u4e9a\u592a\u5730\u533a\u7684\u4e3b\u8981\u5e02\u573a\u8fdb\u884c\u591a\u91cd\u6ce8\u518c\u5907\u6848\u3002<\/p>\n

\u7a81\u7834<\/h2>\n

OncoSil BSI\u7684\u6279\u51c6\u7684\u4e00\u4e2a\u5173\u952e\u65b9\u9762\u662f\u5b83\u7684\u8bbe\u5907\u5df2\u88ab\u6307\u5b9a\u4e3a\u201c\u7a81\u7834\u88c5\u7f6e\u201d\u8fd9\u610f\u5473\u7740\u5b83\u5df2\u7ecf\u8bc1\u660e\u7ed9\u75c5\u4eba\u7684\u4e34\u5e8a\u6548\u76ca\u672a\u6ee1\u8db3\u7684\u533b\u7597\u9700\u6c42\u5371\u53ca\u751f\u547d,\u548c\u5f53\u524d\u7684\u533b\u7597\u9009\u62e9\u4e0d\u8db3\u6216\u91cd\u5927\u98ce\u9669\u3002<\/p>\n

BSI\u7684\u6279\u51c6\u4e5f\u610f\u5473\u7740\u73b0\u5728\u5728\u6b27\u76df\u3001\u82f1\u56fd\u548c\u7f8e\u56fd\uff0cOncoSil\u4f5c\u4e3a\u4e00\u79cd\u7a81\u7834\u6027\u7684\u8bbe\u5907\u6b63\u5f0f\u83b7\u5f97\u8bb8\u53ef\u3002<\/p>\n

\u4e3a\u4e86\u5b9e\u73b0\u5176\u591a\u533a\u57df\u8ba4\u8bc1\uff0c\u4f5c\u4e3aPanCo\u7814\u7a76\u7684\u4e00\u90e8\u5206\uff0cOncoSil\u751f\u6210\u4e86\u201c\u5f15\u4eba\u6ce8\u76ee\u7684\u4e34\u5e8a\u6570\u636e\u201d\u3002\u4e3a\u4e86\u652f\u6301\u81ea\u5df1\u7684\u89c2\u70b9\uff0c\u8be5\u516c\u53f8\u63d0\u4f9b\u4e86\u8be6\u7ec6\u7684\u6bd4\u8f83\u5206\u6790\uff0c\u5373\u6240\u8c13\u7684\u201c\u5e7c\u7a1a\u76f4\u63a5\u6cbb\u7597\u6bd4\u8f83\u201d\uff0c\u5c06PanCO\u7684\u7ed3\u679c\u4e0e\u6700\u5148\u8fdb\u7684\u5c40\u90e8\u665a\u671f\u80f0\u817a\u764c(LAPC)\u6cbb\u7597\u65b9\u6cd5\u8fdb\u884c\u6bd4\u8f83\u3002<\/p>\n

\u6839\u636eOncoSil\uff0c\u6700\u5148\u8fdb\u7684\u6cbb\u7597\u5305\u62ec\u5e7f\u6cdb\u7684\u4e34\u5e8a\u7814\u7a76\u7684\u7cfb\u7edf\u6027\u5316\u7597\uff0c\u4ee5\u53ca\u8bf1\u5bfc\u5316\u7597\u548c\u5408\u5e76\u5316\u7597\u653e\u7597\u65b9\u6848\u652f\u6301\u7684\u4e34\u5e8a\u6307\u5357\u6cbb\u7597\u4e0d\u53ef\u5207\u9664\u7684LAPC\u3002<\/p>\n

\u5728\u83b7\u5f97\u57fa\u7840\u4e34\u5e8a\u6570\u636e\u548c\u6bd4\u8f83\u5206\u6790\u540e\uff0cOncoSil\u5ba3\u5e03\u7ed3\u679c\u8bc1\u5b9e\uff0c\u5f53\u4e0e\u5f53\u4ee3\u7cfb\u7edf\u5316\u7597\u65b9\u6848\u8054\u5408\u4f7f\u7528\u65f6\uff0cOncoSil\u8bbe\u5907\u663e\u793a\u591a\u4e2a\u65b9\u9762\uff0c\u5305\u62ec\u51fa\u8272\u7684\u5c40\u90e8\u75be\u75c5\u63a7\u5236\u3001\u5ef6\u957f\u603b\u4f53\u751f\u5b58\u671f\u3001\u4ee4\u4eba\u9f13\u821e\u7684\u624b\u672f\u5207\u9664\u7387\u548c\u5ef6\u957f\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\u3002<\/p>\n

\u764c\u529e\u7684\u8bbe\u5907\u88ab\u8bc1\u660e\u53ef\u4ee5\u521b\u9020\u66f4\u9ad8\u7684\u75be\u75c5\u63a7\u5236\u7387\uff0c\u663e\u8457\u7684\u80bf\u7624\u4f53\u79ef\u7f29\u5c0f\uff0c\u5e76\u4e14\uff0c\u53ef\u80fd\u6700\u91cd\u8981\u7684\u662f\uff0c\u4ece\u5546\u4e1a\u7684\u89d2\u5ea6\u6765\u770b\uff0c\u6bd4\u53ef\u6bd4\u8f83\u7684\u66ff\u4ee3\u65b9\u6848\u6709\u66f4\u597d\u7684\u7ed3\u679c\u3002<\/p>\n

\u6700\u8fd1\uff0c\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(FDA)\u6388\u4e88\u4e86\u201c\u764c\u529e\u201d\u88c5\u7f6e\u201c\u7a81\u7834\u88c5\u7f6e\u201d\u79f0\u53f7\u3002<\/p>\n

\u5728\u65e9\u76d8\u4ea4\u6613\u4e2d\uff0c\u539f\u764c\u533b\u7597\u7684\u80a1\u4ef7\u4e0a\u6da8\u4e8622%\uff0c\u8fbe\u52300.165\u7f8e\u5143\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u533b\u7597\u8bbe\u5907\u516c\u53f8OncoSil Medical (ASX: OSL)\u5ba3\u5e03\uff0c\u5176\u4e13\u6709\u7684OncoSil\u8bbe\u5907\u7ec8\u4e8e\u83b7\u5f97\u4e86\u82f1\u56fd\u6807\u51c6\u534f\u4f1a(BSI)\u7684CE\u8ba4\u8bc1\uff0c\u8fd9\u662f\u4e00\u79cd\u7ed3\u5408\u5316\u7597\u6cbb\u7597\u5c40\u90e8\u665a\u671f\u80f0\u817a\u764c(LAPC)\u7684\u624b\u6bb5\u3002 \u8be5\u516c\u53f8\u8868\u793a\uff0cOncoSil\u662f\u4e00\u6d41\u7684\u533b\u7597\u8bbe\u5907\uff0c\u5b83\u7531\u542b\u6709\u78f7-32\u7684\u5fae\u7c92\u7ec4\u6210\uff0c\u78f7-32\u662f\u4e00\u79cd\u7eaf\u7cb9\u7684-\u53d1\u5c04\u5668\u653e\u5c04\u6027\u540c\u4f4d\u7d20\uff0c\u901a\u8fc7\u5185\u955c\u8d85\u58f0\u5f15\u5bfc\u76f4\u63a5\u690d\u5165\u60a3\u8005\u7684\u80f0\u817a\u80bf\u7624\u3002 \u636e\u8be5\u533b\u7597\u8bbe\u5907\u516c\u53f8\u79f0\uff0c\u8fd9\u4e00\u521d\u6b65\u6279\u51c6\u662f\u4e00\u4e2a\u91cd\u8981\u7684\u91cc\u7a0b\u7891\uff0c\u4e3a\u8be5\u8bbe\u5907\u5728\u6b27\u76df\u548c\u82f1\u56fd\u5e02\u573a\u9500\u552e\u6253\u5f00\u4e86\u5927\u95e8\u3002 \u8003\u8651\u5230\u6b63\u5728\u8fdb\u884c\u7684\u82f1\u56fd\u9000\u6b27\u8c08\u5224\uff0c\u4ee5\u53ca\u672a\u6765\u51e0\u5e74\u8fd9\u4e24\u4e2a\u5730\u533a\u5728\u5404\u81ea\u8d38\u6613\u653f\u7b56\u4e0a\u53ef\u80fd\u51fa\u73b0\u5206\u6b67\uff0c\u83b7\u5f97\u8fd9\u4e24\u4e2a\u5730\u533a\u7684\u62a4\u7167\u662f\u4e00\u9879\u91cd\u5927\u6210\u5c31\u3002 OncoSil\u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u603b\u7ecf\u7406\u4e39\u5c3c\u5c14\u2022\u80af\u5c3c(Daniel Kenny)\u8868\u793a:\u201c\u5c06OncoSil\u8bbe\u5907\u6307\u5b9a\u4e3a\u7a81\u7834\u6027\u8bbe\u5907\u662f\u5bf9\u6211\u4eec\u5e73\u53f0\u6280\u672f\u7684\u9a8c\u8bc1\uff0c\u8be5\u6280\u672f\u53ef\u7528\u4e8e\u6cbb\u7597\u591a\u79cd\u5b9e\u4f53\u80bf\u7624\u7c7b\u578b\uff0c\u5982\u809d\u810f\u3001\u80c6\u7ba1\uff0c\u5f53\u7136\u8fd8\u6709\u80f0\u817a\u764c\u3002\u201d \u4ed6\u7eed\u8bf4:\u201c\u5728\u53d6\u5f97\u884c\u653f\u957f\u5b98\u8bc4\u5206\u6279\u51c6\u540e\uff0c\u6211\u4eec\u73b0\u5728\u7684\u5de5\u4f5c\u91cd\u70b9\u662f\u5728\u8ba4\u53ef\u884c\u653f\u957f\u5b98\u8bc4\u5206\u8ba4\u8bc1\u7684\u53f8\u6cd5\u7ba1\u8f96\u533a\uff0c\u5904\u7406\u591a\u9879\u6ce8\u518c\u7533\u8bf7\u3002\u201d \u80af\u5c3c\u8fd8\u8bc1\u5b9e\uff0c\u5f53\u524d\u7684COVID-19\u5927\u6d41\u884c\u5e76\u672a\u5f71\u54cdOncoSil\u7684\u76d1\u7ba1\u9014\u5f84\uff0c\u4f46\u4ed6\u786e\u5b9e\u8bc1\u5b9e\uff0c\u5927\u6d41\u884c\u5c06\u5f71\u54cd\u8be5\u516c\u53f8\u7684\u4e0a\u5e02\u51c6\u5907\uff0c\u5305\u62ec\u63a8\u8fdfOncoSil\u5728\u6b27\u6d32\u7684\u4e0a\u5e02\u3002 \u8be5\u516c\u53f8\u9884\u8ba1\uff0c\u5728\u672a\u6765\u51e0\u4e2a\u6708\uff0c\u7531\u4e8e\u65b0\u5de5\u5730\u542f\u52a8\u548c\u57f9\u8bad\u7684\u533b\u9662\u6570\u91cf\u6709\u9650\uff0c\u4ee5\u53ca\u8fd0\u8f93\u548c\u7269\u6d41\u7684\u4e2d\u65ad\uff0c\u5c06\u5bfc\u81f4\u751f\u4ea7\u4e2d\u65ad\u3002 \u968f\u7740\u591a\u4e2a\u5730\u533a\u7684\u8fd0\u8425\u5f97\u5230\u4fdd\u969c\uff0c\u764c\u529e\u5ba3\u5e03\u5c06\u201c\u7acb\u5373\u5f00\u59cb\u201d\u5728\u8ba4\u53efCE\u8ba4\u8bc1\u7684\u4e1c\u76df\u548c\u4e9a\u592a\u5730\u533a\u7684\u4e3b\u8981\u5e02\u573a\u8fdb\u884c\u591a\u91cd\u6ce8\u518c\u5907\u6848\u3002 \u7a81\u7834 OncoSil BSI\u7684\u6279\u51c6\u7684\u4e00\u4e2a\u5173\u952e\u65b9\u9762\u662f\u5b83\u7684\u8bbe\u5907\u5df2\u88ab\u6307\u5b9a\u4e3a\u201c\u7a81\u7834\u88c5\u7f6e\u201d\u8fd9\u610f\u5473\u7740\u5b83\u5df2\u7ecf\u8bc1\u660e\u7ed9\u75c5\u4eba\u7684\u4e34\u5e8a\u6548\u76ca\u672a\u6ee1\u8db3\u7684\u533b\u7597\u9700\u6c42\u5371\u53ca\u751f\u547d,\u548c\u5f53\u524d\u7684\u533b\u7597\u9009\u62e9\u4e0d\u8db3\u6216\u91cd\u5927\u98ce\u9669\u3002 BSI\u7684\u6279\u51c6\u4e5f\u610f\u5473\u7740\u73b0\u5728\u5728\u6b27\u76df\u3001\u82f1\u56fd\u548c\u7f8e\u56fd\uff0cOncoSil\u4f5c\u4e3a\u4e00\u79cd\u7a81\u7834\u6027\u7684\u8bbe\u5907\u6b63\u5f0f\u83b7\u5f97\u8bb8\u53ef\u3002 \u4e3a\u4e86\u5b9e\u73b0\u5176\u591a\u533a\u57df\u8ba4\u8bc1\uff0c\u4f5c\u4e3aPanCo\u7814\u7a76\u7684\u4e00\u90e8\u5206\uff0cOncoSil\u751f\u6210\u4e86\u201c\u5f15\u4eba\u6ce8\u76ee\u7684\u4e34\u5e8a\u6570\u636e\u201d\u3002\u4e3a\u4e86\u652f\u6301\u81ea\u5df1\u7684\u89c2\u70b9\uff0c\u8be5\u516c\u53f8\u63d0\u4f9b\u4e86\u8be6\u7ec6\u7684\u6bd4\u8f83\u5206\u6790\uff0c\u5373\u6240\u8c13\u7684\u201c\u5e7c\u7a1a\u76f4\u63a5\u6cbb\u7597\u6bd4\u8f83\u201d\uff0c\u5c06PanCO\u7684\u7ed3\u679c\u4e0e\u6700\u5148\u8fdb\u7684\u5c40\u90e8\u665a\u671f\u80f0\u817a\u764c(LAPC)\u6cbb\u7597\u65b9\u6cd5\u8fdb\u884c\u6bd4\u8f83\u3002 \u6839\u636eOncoSil\uff0c\u6700\u5148\u8fdb\u7684\u6cbb\u7597\u5305\u62ec\u5e7f\u6cdb\u7684\u4e34\u5e8a\u7814\u7a76\u7684\u7cfb\u7edf\u6027\u5316\u7597\uff0c\u4ee5\u53ca\u8bf1\u5bfc\u5316\u7597\u548c\u5408\u5e76\u5316\u7597\u653e\u7597\u65b9\u6848\u652f\u6301\u7684\u4e34\u5e8a\u6307\u5357\u6cbb\u7597\u4e0d\u53ef\u5207\u9664\u7684LAPC\u3002 \u5728\u83b7\u5f97\u57fa\u7840\u4e34\u5e8a\u6570\u636e\u548c\u6bd4\u8f83\u5206\u6790\u540e\uff0cOncoSil\u5ba3\u5e03\u7ed3\u679c\u8bc1\u5b9e\uff0c\u5f53\u4e0e\u5f53\u4ee3\u7cfb\u7edf\u5316\u7597\u65b9\u6848\u8054\u5408\u4f7f\u7528\u65f6\uff0cOncoSil\u8bbe\u5907\u663e\u793a\u591a\u4e2a\u65b9\u9762\uff0c\u5305\u62ec\u51fa\u8272\u7684\u5c40\u90e8\u75be\u75c5\u63a7\u5236\u3001\u5ef6\u957f\u603b\u4f53\u751f\u5b58\u671f\u3001\u4ee4\u4eba\u9f13\u821e\u7684\u624b\u672f\u5207\u9664\u7387\u548c\u5ef6\u957f\u65e0\u8fdb\u5c55\u751f\u5b58\u671f\u3002 \u764c\u529e\u7684\u8bbe\u5907\u88ab\u8bc1\u660e\u53ef\u4ee5\u521b\u9020\u66f4\u9ad8\u7684\u75be\u75c5\u63a7\u5236\u7387\uff0c\u663e\u8457\u7684\u80bf\u7624\u4f53\u79ef\u7f29\u5c0f\uff0c\u5e76\u4e14\uff0c\u53ef\u80fd\u6700\u91cd\u8981\u7684\u662f\uff0c\u4ece\u5546\u4e1a\u7684\u89d2\u5ea6\u6765\u770b\uff0c\u6bd4\u53ef\u6bd4\u8f83\u7684\u66ff\u4ee3\u65b9\u6848\u6709\u66f4\u597d\u7684\u7ed3\u679c\u3002 \u6700\u8fd1\uff0c\u7f8e\u56fd\u98df\u54c1\u548c\u836f\u7269\u7ba1\u7406\u5c40(FDA)\u6388\u4e88\u4e86\u201c\u764c\u529e\u201d\u88c5\u7f6e\u201c\u7a81\u7834\u88c5\u7f6e\u201d\u79f0\u53f7\u3002 \u5728\u65e9\u76d8\u4ea4\u6613\u4e2d\uff0c\u539f\u764c\u533b\u7597\u7684\u80a1\u4ef7\u4e0a\u6da8\u4e8622%\uff0c\u8fbe\u52300.165\u7f8e\u5143\u3002<\/p>\n","protected":false},"author":5,"featured_media":189,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[18],"yoast_head":"\nOncoSil Medical\u7684\u80f0\u817a\u80bf\u7624\u540c\u4f4d\u7d20\u83b7\u5f97CE\u6807\u5fd7\u548c\u7a81\u7834\u88c5\u7f6e\u8bbe\u8ba1<\/title>\n<meta name=\"description\" content=\"\u533b\u7597\u8bbe\u5907\u516c\u53f8OncoSil Medical (ASX: OSL)\u5ba3\u5e03\uff0c\u5176\u4e13\u6709\u7684OncoSil\u8bbe\u5907\u7ec8\u4e8e\u83b7\u5f97\u4e86\u82f1\u56fd\u6807\u51c6\u534f\u4f1a(BSI)\u7684CE\u8ba4\u8bc1\uff0c\u8fd9\u662f\u4e00\u79cd\u7ed3\u5408\u5316\u7597\u6cbb\u7597\u5c40\u90e8\u665a\u671f\u80f0\u817a\u764c(LAPC)\u7684\u624b\u6bb5\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OncoSil Medical\u7684\u80f0\u817a\u80bf\u7624\u540c\u4f4d\u7d20\u83b7\u5f97CE\u6807\u5fd7\u548c\u7a81\u7834\u88c5\u7f6e\u8bbe\u8ba1\" \/>\n<meta property=\"og:description\" content=\"\u533b\u7597\u8bbe\u5907\u516c\u53f8OncoSil Medical (ASX: OSL)\u5ba3\u5e03\uff0c\u5176\u4e13\u6709\u7684OncoSil\u8bbe\u5907\u7ec8\u4e8e\u83b7\u5f97\u4e86\u82f1\u56fd\u6807\u51c6\u534f\u4f1a(BSI)\u7684CE\u8ba4\u8bc1\uff0c\u8fd9\u662f\u4e00\u79cd\u7ed3\u5408\u5316\u7597\u6cbb\u7597\u5c40\u90e8\u665a\u671f\u80f0\u817a\u764c(LAPC)\u7684\u624b\u6bb5\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/oncosil-medical-obtains-ce-mark-breakthrough-device-designation-pancreatic-tumour-isotope\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2020-04-01T00:19:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T18:02:08+00:00\" \/>\n<meta name=\"author\" content=\"Small Caps\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"OncoSil Medical\u7684\u80f0\u817a\u80bf\u7624\u540c\u4f4d\u7d20\u83b7\u5f97CE\u6807\u5fd7\u548c\u7a81\u7834\u88c5\u7f6e\u8bbe\u8ba1\" \/>\n<meta name=\"twitter:description\" content=\"\u533b\u7597\u8bbe\u5907\u516c\u53f8OncoSil Medical (ASX: OSL)\u5ba3\u5e03\uff0c\u5176\u4e13\u6709\u7684OncoSil\u8bbe\u5907\u7ec8\u4e8e\u83b7\u5f97\u4e86\u82f1\u56fd\u6807\u51c6\u534f\u4f1a(BSI)\u7684CE\u8ba4\u8bc1\uff0c\u8fd9\u662f\u4e00\u79cd\u7ed3\u5408\u5316\u7597\u6cbb\u7597\u5c40\u90e8\u665a\u671f\u80f0\u817a\u764c(LAPC)\u7684\u624b\u6bb5\u3002\" \/>\n<meta name=\"twitter:image\" content=\"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/04\/OncoSil-Medical-breakthrough-device-treatment-pancreatic-cancer-CE-Marking-approval-ASX-OSL.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Small Caps\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/oncosil-medical-obtains-ce-mark-breakthrough-device-designation-pancreatic-tumour-isotope\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/oncosil-medical-obtains-ce-mark-breakthrough-device-designation-pancreatic-tumour-isotope\/\",\"name\":\"OncoSil Medical\u7684\u80f0\u817a\u80bf\u7624\u540c\u4f4d\u7d20\u83b7\u5f97CE\u6807\u5fd7\u548c\u7a81\u7834\u88c5\u7f6e\u8bbe\u8ba1\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2020-04-01T00:19:13+00:00\",\"dateModified\":\"2023-08-29T18:02:08+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\"},\"description\":\"\u533b\u7597\u8bbe\u5907\u516c\u53f8OncoSil Medical (ASX: OSL)\u5ba3\u5e03\uff0c\u5176\u4e13\u6709\u7684OncoSil\u8bbe\u5907\u7ec8\u4e8e\u83b7\u5f97\u4e86\u82f1\u56fd\u6807\u51c6\u534f\u4f1a(BSI)\u7684CE\u8ba4\u8bc1\uff0c\u8fd9\u662f\u4e00\u79cd\u7ed3\u5408\u5316\u7597\u6cbb\u7597\u5c40\u90e8\u665a\u671f\u80f0\u817a\u764c(LAPC)\u7684\u624b\u6bb5\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/oncosil-medical-obtains-ce-mark-breakthrough-device-designation-pancreatic-tumour-isotope\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/oncosil-medical-obtains-ce-mark-breakthrough-device-designation-pancreatic-tumour-isotope\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/oncosil-medical-obtains-ce-mark-breakthrough-device-designation-pancreatic-tumour-isotope\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OncoSil Medical\u7684\u80f0\u817a\u80bf\u7624\u540c\u4f4d\u7d20\u83b7\u5f97CE\u6807\u5fd7\u548c\u7a81\u7834\u88c5\u7f6e\u8bbe\u8ba1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74\",\"name\":\"Small Caps\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g\",\"caption\":\"Small Caps\"},\"description\":\"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=5\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"OncoSil Medical\u7684\u80f0\u817a\u80bf\u7624\u540c\u4f4d\u7d20\u83b7\u5f97CE\u6807\u5fd7\u548c\u7a81\u7834\u88c5\u7f6e\u8bbe\u8ba1","description":"\u533b\u7597\u8bbe\u5907\u516c\u53f8OncoSil Medical (ASX: OSL)\u5ba3\u5e03\uff0c\u5176\u4e13\u6709\u7684OncoSil\u8bbe\u5907\u7ec8\u4e8e\u83b7\u5f97\u4e86\u82f1\u56fd\u6807\u51c6\u534f\u4f1a(BSI)\u7684CE\u8ba4\u8bc1\uff0c\u8fd9\u662f\u4e00\u79cd\u7ed3\u5408\u5316\u7597\u6cbb\u7597\u5c40\u90e8\u665a\u671f\u80f0\u817a\u764c(LAPC)\u7684\u624b\u6bb5\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"OncoSil Medical\u7684\u80f0\u817a\u80bf\u7624\u540c\u4f4d\u7d20\u83b7\u5f97CE\u6807\u5fd7\u548c\u7a81\u7834\u88c5\u7f6e\u8bbe\u8ba1","og_description":"\u533b\u7597\u8bbe\u5907\u516c\u53f8OncoSil Medical (ASX: OSL)\u5ba3\u5e03\uff0c\u5176\u4e13\u6709\u7684OncoSil\u8bbe\u5907\u7ec8\u4e8e\u83b7\u5f97\u4e86\u82f1\u56fd\u6807\u51c6\u534f\u4f1a(BSI)\u7684CE\u8ba4\u8bc1\uff0c\u8fd9\u662f\u4e00\u79cd\u7ed3\u5408\u5316\u7597\u6cbb\u7597\u5c40\u90e8\u665a\u671f\u80f0\u817a\u764c(LAPC)\u7684\u624b\u6bb5\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/oncosil-medical-obtains-ce-mark-breakthrough-device-designation-pancreatic-tumour-isotope\/","og_site_name":"smallcapsCN","article_published_time":"2020-04-01T00:19:13+00:00","article_modified_time":"2023-08-29T18:02:08+00:00","author":"Small Caps","twitter_card":"summary_large_image","twitter_title":"OncoSil Medical\u7684\u80f0\u817a\u80bf\u7624\u540c\u4f4d\u7d20\u83b7\u5f97CE\u6807\u5fd7\u548c\u7a81\u7834\u88c5\u7f6e\u8bbe\u8ba1","twitter_description":"\u533b\u7597\u8bbe\u5907\u516c\u53f8OncoSil Medical (ASX: OSL)\u5ba3\u5e03\uff0c\u5176\u4e13\u6709\u7684OncoSil\u8bbe\u5907\u7ec8\u4e8e\u83b7\u5f97\u4e86\u82f1\u56fd\u6807\u51c6\u534f\u4f1a(BSI)\u7684CE\u8ba4\u8bc1\uff0c\u8fd9\u662f\u4e00\u79cd\u7ed3\u5408\u5316\u7597\u6cbb\u7597\u5c40\u90e8\u665a\u671f\u80f0\u817a\u764c(LAPC)\u7684\u624b\u6bb5\u3002","twitter_image":"http:\/\/smallcaps-production.test\/wp-content\/uploads\/2020\/04\/OncoSil-Medical-breakthrough-device-treatment-pancreatic-cancer-CE-Marking-approval-ASX-OSL.jpg","twitter_misc":{"Written by":"Small Caps"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/oncosil-medical-obtains-ce-mark-breakthrough-device-designation-pancreatic-tumour-isotope\/","url":"https:\/\/smallcapscn.x5view.co\/oncosil-medical-obtains-ce-mark-breakthrough-device-designation-pancreatic-tumour-isotope\/","name":"OncoSil Medical\u7684\u80f0\u817a\u80bf\u7624\u540c\u4f4d\u7d20\u83b7\u5f97CE\u6807\u5fd7\u548c\u7a81\u7834\u88c5\u7f6e\u8bbe\u8ba1","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2020-04-01T00:19:13+00:00","dateModified":"2023-08-29T18:02:08+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74"},"description":"\u533b\u7597\u8bbe\u5907\u516c\u53f8OncoSil Medical (ASX: OSL)\u5ba3\u5e03\uff0c\u5176\u4e13\u6709\u7684OncoSil\u8bbe\u5907\u7ec8\u4e8e\u83b7\u5f97\u4e86\u82f1\u56fd\u6807\u51c6\u534f\u4f1a(BSI)\u7684CE\u8ba4\u8bc1\uff0c\u8fd9\u662f\u4e00\u79cd\u7ed3\u5408\u5316\u7597\u6cbb\u7597\u5c40\u90e8\u665a\u671f\u80f0\u817a\u764c(LAPC)\u7684\u624b\u6bb5\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/oncosil-medical-obtains-ce-mark-breakthrough-device-designation-pancreatic-tumour-isotope\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/oncosil-medical-obtains-ce-mark-breakthrough-device-designation-pancreatic-tumour-isotope\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/oncosil-medical-obtains-ce-mark-breakthrough-device-designation-pancreatic-tumour-isotope\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"OncoSil Medical\u7684\u80f0\u817a\u80bf\u7624\u540c\u4f4d\u7d20\u83b7\u5f97CE\u6807\u5fd7\u548c\u7a81\u7834\u88c5\u7f6e\u8bbe\u8ba1"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/ba96c5f4870849ab11e50adb62f2df74","name":"Small Caps","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5631bbe5d71ed71e3a6c301df6f973d0?s=96&d=mm&r=g","caption":"Small Caps"},"description":"Small Caps provides coverage on Australian ASX listed small cap stocks across all sectors: mining, resources, energy, biotech, technology, juniors and IPOs.","url":"https:\/\/smallcapscn.x5view.co\/?author=5"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/188"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=188"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/188\/revisions"}],"predecessor-version":[{"id":7353,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/188\/revisions\/7353"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/189"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=188"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=188"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}